Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-26 Purchase | 2023-04-28 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 50,999 | $0.74294 | $37,889 | 399,417 (Direct) | View |
| 2023-02-28 Purchase | 2023-03-02 06:24 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 5,000 | $1.52 | $7,600 | 344,918 (Direct) | View |
| 2023-01-18 Purchase | 2023-01-19 06:05 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 6,800 | $1.62 | $11,016 | 339,918 (Direct) | View |
| 2022-12-14 Purchase | 2022-12-15 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 23,000 | $1.2937 | $29,755 | 333,118 (Direct) | View |
| 2022-11-18 Purchase | 2022-11-22 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 13,900 | $1.41 | $19,599 | 310,118 (Direct) | View |
| 2022-11-03 Purchase | 2022-11-04 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 9,200 | $1.52 | $13,984 | 296,218 (Direct) | View |
| 2022-11-02 Purchase | 2022-11-03 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 6,000 | $1.59 | $9,540 | 287,018 (Direct) | View |
| 2022-10-07 Purchase | 2022-10-11 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 5,000 | $1.77 | $8,850 | 277,518 (Direct) | View |
| 2022-10-03 Purchase | 2022-10-05 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 5,000 | $1.67 | $8,350 | 272,518 (Direct) | View |
| 2022-09-22 Purchase | 2022-09-26 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 5,000 | $1.76 | $8,800 | 267,518 (Direct) | View |
| 2022-07-22 Purchase | 2022-07-25 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 4,500 | $1.85 | $8,325 | 262,518 (Direct) | View |
| 2022-07-12 Purchase | 2022-07-14 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 6,000 | $1.855 | $11,130 | 258,018 (Direct) | View |
| 2022-05-09 Purchase | 2022-05-11 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 10,000 | $1.85 | $18,500 | 252,018 (Direct) | View |
| 2022-05-06 Purchase | 2022-05-10 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 2,500 | $1.97 | $4,925 | 242,018 (Direct) | View |
| 2022-04-29 Purchase | 2022-05-03 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 5,000 | $1.9709 | $9,855 | 239,518 (Direct) | View |
| 2022-04-21 Purchase | 2022-04-25 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 4,500 | $2.3 | $10,350 | 234,518 (Direct) | View |
| 2022-04-08 Purchase | 2022-04-12 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 2,000 | $2.5 | $5,000 | 226,518 (Direct) | View |
| 2022-03-30 Purchase | 2022-04-01 06:05 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 4,000 | $2.7 | $10,800 | 224,518 (Direct) | View |
| 2022-03-21 Purchase | 2022-03-23 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 1,200 | $2.45 | $2,940 | 220,518 (Direct) | View |
| 2021-11-18 Purchase | 2021-11-22 4:21 pm | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 4,181 | $2.8298 | $11,831 | 219,318 (Direct) | View |
| 2021-11-05 Purchase | 2021-11-09 07:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 4,000 | $3.4137 | $13,655 | 215,137 (Direct) | View |
| 2021-08-16 Purchase | 2021-08-18 06:05 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 3,000 | $3.56 | $10,680 | 207,732 (Direct) | View |
| 2021-01-27 Purchase | 2021-01-28 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 11,000 | $8.9792 | $98,771 | 201,232 (Direct) | View |
| 2020-12-29 Purchase | 2020-12-30 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 1,000 | $9.98 | $9,980 | 190,232 (Direct) | View |
| 2020-10-21 Purchase | 2020-10-23 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 2,000 | $4.3845 | $8,769 | 189,232 (Direct) | View |
| 2020-09-23 Purchase | 2020-09-25 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 5,000 | $4.7198 | $23,599 | 186,882 (Direct) | View |
| 2020-09-04 Purchase | 2020-09-09 06:00 am | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 10,000 | $2.575 | $25,750 | 181,882 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-24 4:05 pm | N/A 2034-06-20 | Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director | 2,200 | $0 | 2,200 (Direct) | View |
| 2024-05-21 Option Award | 2024-05-23 7:16 pm | N/A 2034-05-20 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-04-20 Option Award | 2024-03-13 5:56 pm | N/A N/A | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES PRESIDENT AND CEO | 3,500 | $0.1377 | 924,717 (Direct) | View |
| 2023-10-20 Option Award | 2024-03-13 5:56 pm | N/A N/A | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES PRESIDENT AND CEO | 3,500 | $0.1333 | 924,717 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-13 5:56 pm | N/A 2034-03-11 | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES PRESIDENT AND CEO | 518,300 | $0 | 924,717 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-28 | Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 7:35 pm | N/A 2033-05-22 | 4D Molecular Therapeutics Inc. | FMDT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 7:55 pm | N/A 2033-01-31 | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 332,000 | $0 | 332,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 6:00 pm | N/A 2032-06-16 | Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 7:06 pm | N/A 2032-05-22 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 5:00 pm | N/A 2032-01-27 | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 265,000 | $0 | 265,000 (Direct) | View |
| 2021-05-25 Option Award | 2021-05-27 6:06 pm | N/A 2031-05-25 | Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-19 8:36 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 6:00 pm | N/A 2031-01-28 | Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO | 180,000 | $0 | 180,000 (Direct) | View |
Ownership | 2020-12-10 7:18 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 0 | $0 | 100,368 (Direct) | View |